Rat BNP-45 is the main circulating form of BNP in rat plasma. To under
stand the role of BNP in physiological and pathophysiological conditio
ns, a specific radioimmunoassay (RIA) for the quantitative determinati
on of the peptide in plasma and tissues is necessary. An assay using r
BNP-45 as the standard in conjunction with antisera directed against t
his peptide has not been described in the literature, though some inve
stigators have reported values ranging from 0.73-2.0 pmol/L using eith
er BNP-26 or BNP-32 as the standard peptide. Unfortunately, these form
s of BNP do not exist in rat plasma. In our studies, we have developed
a specific RIA for rBNP-45 using rBNP-45 as the standard peptide and
Tyr(o)-rBNP-45 as the radioligand. We have used two specific antisera
for assay purposes; one against rBNP-45, and the second to a peptide c
omposed of the first 20 amino acids of rBNP-45 (rBNP[1-20]). The recov
ery of various amounts of rBNP-45 added to control plasma was 50-80% d
epending on the method of extraction and purification. The interassay
and intraassay coefficients of variation were 12% and 6% respectively.
Values obtained were similar for blood sampled by either cardiac punc
ture, decapitation, or aortic puncture. The method was used to measure
rBNP-45 in the plasma of normal (WKY) and Spontaneously Hypertensive
(SHR) rats. The values obtained were 5.46 +/- 0.43 and 19.6 +/- 2.36 p
mol/L respectively. The rat atrial natriuretic peptide (ANP[99-126]) v
alues in the same extracts were 23.2 +/- 0.45 and 51.6 +/- 3.16 pmol/L
.